If you like LS and NAV4694 you will like what NAV5001 does!
Company they acquired from (alse) had already tested on over 600 patients with strong results on Parkinson and positive results on adhd and started DLB. Alse just ran out of funding around 2008/2009 collapse. Also my view from here on navb will trade more on the coupling of financial expectations along with product expectations. (no one knows what the very large short covering will generate in pricing so it is a wild card that will only play out once and will not speak to the longer term financial health of navb)